Top 10 Transactions (February 9 - 13, 2026)

Top 10 Transactions (February 9 - 13, 2026)

Top 10 Transactions (February 9 - 13, 2026)
8:13

The private company data space is vast, fragmented, and often overwhelming. Deal sourcing teams are faced with endless streams of announcements, filings, atSnd rumors, making it difficult to pinpoint the transactions that actually matter.

That’s why inside Dakota Marketplace, we’ve zeroed in on this space. We’ve created a centralized resource where deal sourcers can easily find and track the exact deals they’re looking for.

In this article, we’ve curated 10 top transactions from last week that stood out in the marketplace and signal key trends shaping the deal landscape. By the end of this, you’ll have a better understanding of these deals.

1. Anthropic - Series G

  • Transaction Date: 2/12/2026
  • Type: Growth Equity
  • Sector: Information Technology
  • Transaction Value: $30B
  • Participants: GIC, Coatue

Anthropic raised $30 billion in a Series G round led by GIC and Coatue, reaching a $380 billion post-money valuation as it accelerates enterprise AI and coding infrastructure expansion. The funding supports continued growth of its Claude platform, which has scaled rapidly across enterprise customers, cloud platforms, and AI hardware providers while surpassing $14 billion in run-rate revenue.

2. CyberArk - Strategic Acquisition

  • Transaction Date: 2/11/2026
  • Type: Acquisition/Merger
  • Sector: Information Technology
  • Transaction Value: $25B
  • Participants: Palo Alto Networks

Palo Alto Networks has completed its acquisition of CyberArk in a transaction valued at approximately $25 billion, formally establishing Identity Security as a core pillar of its AI-driven cybersecurity platform strategy. The deal integrates CyberArk’s privileged access and identity security capabilities across human, machine, and AI identities, strengthening Palo Alto Networks’ position as a unified security provider for enterprises operating in the AI era.

3. BD's Biosciences & Diagnostic Solutions Business - Merger

  • Transaction Date: 2/9/2026
  • Type: Acquisition/Merger
  • Sector: Health Care
  • Transaction Value: $18B
  • Participants: Waters

BD has completed the spin-off of its Biosciences & Diagnostic Solutions business and its combination with Waters Corporation in a transaction valuing the unit at approximately $18.8 billion, with BD shareholders receiving Waters shares and BD receiving $4 billion in cash. The deal advances BD’s strategy to become a focused pure-play MedTech company, with proceeds earmarked for share repurchases and debt reduction while Waters expands its life sciences and diagnostics capabilities.

4. Schroders - Take-Private

  • Transaction Date: 2/12/2026
  • Type: Buyout/Private Equity
  • Sector: Financials
  • Transaction Value: $13.5B
  • Participants: Nuveen

Nuveen has agreed to acquire Schroders in a board-recommended cash transaction valued at approximately £9.9 billion, creating a global asset management firm with nearly $2.5 trillion in combined assets under management. The deal strengthens Nuveen’s public-to-private investment platform and global distribution footprint, with Schroders operating as a standalone business within Nuveen following expected closing in Q4 2026, subject to shareholder and regulatory approvals.

5. Firmus Technologies - Direct Lending

  • Transaction Date: 2/9/2026
  • Type: Credit
  • Sector: Industrials
  • Transaction Value: $10B
  • Participants: Blackstone, Coatue

Firmus has secured a $10 billion debt financing facility led by Blackstone and supported by Coatue to accelerate the national rollout of its energy-efficient AI Factory platform across Australia. The funding will scale Project Southgate to meet rising global demand for high-performance AI compute, positioning Australia as a key hub in the expanding AI infrastructure buildout.

6. Urbaser - Secondary Buyout

  • Transaction Date: 2/12/2026
  • Type: Buyout/Private Equity
  • Sector: Industrials
  • Transaction Value: $6.6B
  • Participants: Blackstone, EQT

Platinum Equity has agreed to sell global environmental services platform Urbaser to Blackstone and EQT for approximately $6.6 billion, following a multi-year transformation that significantly expanded revenue, EBITDA, and backlog. The deal marks a successful exit after Platinum’s 2021 acquisition, with the firm retaining Urbaser’s Argentina business while transferring the core environmental infrastructure platform to new ownership pending regulatory approval.

7. Valaris Limited - Strategic Acquisition

  • Transaction Date: 2/9/2026
  • Type: Acquisition/Merger
  • Sector: Energy
  • Transaction Value: $5.8B
  • Participants: Transocean

Transocean has agreed to acquire Valaris in an all-stock transaction valued at approximately $5.8 billion, creating the world’s highest-specification offshore drilling fleet with a pro forma enterprise value of $17 billion. The combination unites 73 rigs across deepwater and shallow basins, is expected to generate more than $200 million in cost synergies, and positions the merged company to capitalize on a multi-year offshore drilling upcycle.

8. Vantage Data Centers - Direct Lending

  • Transaction Date: 2/10/2026
  • Type: Credit
  • Sector: Real Estate
  • Transaction Value: $2.4B
  • Participants: Ares

Ares has arranged a $2.4 billion debt facility for Vantage Data Centers, committing approximately $1.6 billion to refinance existing debt and support the expansion of its North American hyperscale data center portfolio. The financing strengthens Vantage’s ability to meet accelerating cloud and AI demand across its 17-campus, 4+ GW platform, which is fully leased to predominantly investment-grade customers.

9. Orna Therapeutics - Strategic Acquisition

  • Transaction Date: 2/9/2026
  • Type: Acquisition/Merger
  • Sector: Health Care
  • Transaction Value: $2.4B
  • Participants: Eli Lilly

Eli Lilly has agreed to acquire Orna Therapeutics in a deal valued at up to $2.4 billion, expanding its immunology pipeline with Orna’s circular RNA and lipid nanoparticle platform for in vivo CAR-T therapies. The acquisition centers on ORN-252, a CD19-targeting therapy for B cell-driven autoimmune diseases, and aims to advance next-generation genetic medicines that could overcome the cost and complexity of traditional cell therapies.

10. TKC Holdings - Debt Refinancing / Dividend Financing

  • Transaction Date: 2/12/2026
  • Type: Credit
  • Sector: Consumer Discretionary
  • Transaction Value: $2.3M
  • Participants: HIG Capital

Prison services provider TKC has secured a $2.3 billion loan to refinance existing debt and fund a dividend, tapping credit markets amid continued investor appetite for leveraged transactions. The refinancing strengthens the company’s capital structure while enabling a shareholder payout backed by its correctional services cash flows.

Transactions with Dakota Marketplace

At Dakota, we understand how important it is to stay current on deal activity as it happens. That’s why our editorial team is constantly monitoring the news for real-time updates on platform investments, add-ons, divestitures, and more. Each day, we deliver these highlights directly to your inbox through our transactions newsletter.

Inside Dakota Marketplace, the transactions tab gives you access to structured, filterable data complete with dates, deal structure, sectors, and financials, so you can build a feed tailored to your specific interests.

Whether you're evaluating a new investment opportunity or tracking trends in a target sector or segment, Dakota Marketplace helps you cut through the noise and focus on what matters most.

For more information on these transactions and a deeper dive into their industries and sub-industries, book a demo of Dakota Marketplace.

Cate Costin, Marketing Associate

Written By: Cate Costin, Marketing Associate